Legend Biotech (LEGN)
(Real Time Quote from BATS)
$45.05 USD
+0.67 (1.51%)
Updated May 15, 2024 10:18 AM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/20/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 44.83% |
ABR | 1.33 |
Earnings ESP
|
0.95% |
---|---|
Current Year | -1.14 |
Next Year | 0.25 |
EPS (TTM) | -1.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 118.89M | 131.93M | 571.15M | 1.18B |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 159.70M | 135.25M | 653.40M | 1.53B |
Low Estimate | 92.55M | 126.00M | 501.23M | 920.00M |
Year ago Sales | 73.33M | 96.01M | 285.14M | 571.15M |
Year over Year Growth Est. | 62.12% | 37.41% | 100.30% | 107.36% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.37 | -1.14 | 0.25 |
# of Estimates | 6 | 6 | 8 | 7 |
Most Recent Consensus | -0.34 | -0.24 | -1.09 | 0.36 |
High Estimate | -0.12 | -0.18 | -0.43 | 2.14 |
Low Estimate | -0.68 | -0.61 | -2.00 | -0.79 |
Year ago EPS | -0.27 | -0.17 | -1.47 | -1.14 |
Year over Year Growth Est. | -29.63% | -117.65% | 22.45% | 121.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 2 | 2 |
Up Last 30 Days | 1 | 2 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 2 | 0 |
Down Last 60 Days | 3 | 3 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.37 | -1.14 | 0.25 |
7 Days Ago | -0.43 | -0.43 | -1.36 | 0.08 |
30 Days Ago | -0.42 | -0.43 | -1.34 | 0.08 |
60 Days Ago | -0.39 | -0.42 | -1.39 | 0.12 |
90 Days Ago | -0.49 | -0.55 | -1.74 | 0.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.28 | -1.11 | -0.63 |
Zacks Consensus Estimate | -0.35 | -0.37 | -1.14 | 0.25 |
Earnings ESP | 0.95% | 24.66% | 2.71% | -354.37% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.40 | -0.17 | -0.27 | NA |
Estimate | -0.29 | -0.70 | -0.56 | -0.69 | NA |
Difference | 0.13 | 0.30 | 0.39 | 0.42 | 0.31 |
Surprise | 44.83% | 42.86% | 69.64% | 60.87% | 54.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more